This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Apr. 17, 2012

   NAMCP   AAMCN    AAIHDS    CME/CEU    JMCM    Contact Us  

Targeting critical pathways

We are improving cancer treatment by developing monoclonal antibodies that target cancer stem cells.

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs

Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!


 Managed Healthcare News
Click Here to visit the Population Health Management Institute

Without healthcare reform, 20-somethings out of luck
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
About 2.5 million young adults from age 19 to 25 attained health coverage as a result of the Affordable Care Act, according to the Department of Health and Human Services. Prior to the law's approval, some 13.7 million young adults were uninsured, nearly one-third of the nation's total uninsured population, according to the nonprofit Kaiser Family Foundation. More

Clinical & Economic Utility of a Non-invasive Prenatal Test

Join Susan Garfield, DrPH, Vice President, Bridgehead International, and Anthony Odibo, MD, MSCE at NAMCP’s
Spring Managed Care Forum.

Friday, April 27th, 1:10 – 2:10 PM

Gaylord Palms Hotel
Orlando, FL

States seek curb on patient bills for costly drugs
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Lawmakers in at least 20 states, from Maine to Hawaii, have introduced bills that would limit out-of-pocket payments by consumers for expensive drugs used to treat diseases like cancer, rheumatoid arthritis, multiple sclerosis and inherited disorders. Pharmaceutical companies would also benefit from such legislation because high co-payments discourage patients from taking their medicines. The pharmaceutical giant Pfizer has been helping the legislative drive behind the scenes. More

Medicare moves to tie doctors' pay to quality and cost of care
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Twenty-thousand physicians in four Midwest states received a glimpse into their financial future last month. Landing in their email inboxes were links to reports from Medicare showing the amount their patients cost on average as well as the quality of the care they provided. The reports also showed how Medicare spending on each doctor's patients compared with their peers in Kansas, Iowa, Missouri and Nebraska. More

 FDA: New Treatments & Technology

FDA adds sexual side effects warning to baldness drug Propecia
CBS News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Merck's baldness drug Propecia is taken by many American men with thinning hairlines. The drug, known generically as finasteride, is also sold by Merck as a different pill Proscar to treat an enlarged prostate. The Food and Drug Administration has announced label changes for both drugs, saying they could cause sexual side effects in the men who take them. More

FDA seeks information on HyQ therapy
Down Jones Newswires via Fox Business    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Baxter International and Halozyme Therapeutics received a Food and Drug Administration request for additional information related to the long-term use of their investigational product called HyQ. The FDA's request delays any potential approval of HyQ, a treatment that aims to allow physicians to tailor antibody drug therapy to lifestyle and medical needs of patients with immune-system disorders. More

Introducing mySentry™ from Medtronic...

The world’s first remote glucose monitor designed to provide protection from overnight hypoglycemia. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE

Click Here to visit the Oncology Institute

Study: Exercise could lower breast cancer patient fatigue, depression
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Exercise could be the secret weapon to help breast cancer patients combat common side effects of cancer and cancer treatments. A new study that was presented at the annual meeting of the Society of Behavioral Medicine shows that physical activity could help women being treated for breast cancer to have less fatigue and depression. More

Cancer patient spouses may have raised risk of heart disease, stroke
HealthDay news via Doctors Lounge    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The spouses of cancer patients are at increased risk of heart disease and stroke, a new study suggests. Researchers said the explanation might be that stress takes a toll on the health of caregivers. Using the national Swedish cancer registry and the Swedish inpatient registry, researchers found that risk for heart disease and stroke increased by 13 to 29 percent in people whose partner had cancer. More

 Prevention & Wellness
Click Here to visit the Center for Preventive Health and Lifestyle Medicine

Why shift work and sleeplessness lead to weight gain, diabetes
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Studies show that shift work and other sleep disturbances like jet lag can disrupt your body clock and increase the risks of obesity and diabetes. But, until now, researchers haven't really been sure exactly how these changes affect the body's metabolism. To find out, Harvard researchers invited 21 men and women to participate in a study in a controlled laboratory setting, where they would have their sleep-wake cycles purposefully disrupted. More

Nation's nutrition is good, but some disparities remain
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Deficiencies in nutrients and vitamins often vary by age, gender, race and ethnicity, according to a recent report by the Centers for Disease Control and Prevention. The most significant deficiency involves blacks and vitamin D. Thirty-one percent of that population has insufficient levels of the vitamin, compared with 12 percent of Mexican-Americans and 3 percent of whites. More

 Genomics and Biotech
Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute

Personalized medicine game changer on drug creation, distribution
Fox Business    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Technological innovations and compelling science have accelerated the understanding of human genetics, and experts expect the developments to usher in increased biomedical research and a clinical paradigm, resulting in more personalized medicine. Genomic DNA sequencing has led pathologists to seek out biomarkers that reveal large numbers of proteins and genetic patterns in the blood, urine or tissues or saliva extracted from the cheek to uncover one million SNPS, or DNA sequence variations. More

Texas approves rules governing experimental stem cell therapies
The Associated Press via The Washington Psot    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Texas Medical Board approved new rules on experimental stem cell therapies such as the one Gov. Rick Perry underwent during back surgery, despite objections they don't do enough to protect patients and could led to an explosion of doctors promoting unproven, expensive treatments. The rules require patients to give their consent, and a review board must approve the procedure before doctors use stem cell treatments. More

 Behavioral Health
Click Here to visit the Behavioral Health Institute

Study: More older moms don't stop with 1 baby
msnbc    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An increasing proportion of women who have their first baby at age 35 or older aren't stopping with one child, according to a new report from the National Center for Health Statistics. Among all women whose first birth occurred between ages 35 and 44, nearly 40 percent had at least two children in 2006-2010, up from 26 percent recorded in 1995. More

Study: Seizures often misdiagnosed as epilepsy, actually stress
CBS News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Seizures are the only visible symptom of epilepsy — but that doesn't mean all seizures indicate epilepsy, a new study shows. Many patients are admitted to hospitals for seizures that look like epilepsy but are actually triggered by stress and poor coping skills, researchers found. More

"According to the Mayo Clinic, about 2 in 100 people in the United States will experience an unprovoked seizure once in life. However, at least two unprovoked seizures are generally required for an epilepsy diagnosis."
Managed Care eNews
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Managed Care eNews was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
April 10, 2012
April 3, 2012
March 27, 2012
March 20, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063